Literature DB >> 28289348

Risk Factors and Treatment for Hepatocellular Carcinoma.

Robert G Gish1.   

Abstract

Entities:  

Year:  2006        PMID： 28289348      PMCID： PMC5345210     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

Review 2.  Recurrence of diseases following orthotopic liver transplantation.

Authors:  David S Kotlyar; Mical S Campbell; K Rajender Reddy
Journal:  Am J Gastroenterol       Date:  2006-06       Impact factor: 10.864

3.  The role of contrast-enhanced ultrasound on the diagnosis of small hepatocellular carcinoma (</=3cm) in patients with cirrhosis.

Authors:  Min Hua Chen; Ying Dai; Kun Yan; Zhi Hui Fan; Shan Shan Yin; Wei Yang; Wei Wu; Yan Bin Wang; Ji You Li
Journal:  Hepatol Res       Date:  2006-06-19       Impact factor: 4.288

Review 4.  New frontiers in biomarkers for hepatocellular carcinoma.

Authors:  G Giannelli; S Antonaci
Journal:  Dig Liver Dis       Date:  2006-06-19       Impact factor: 4.088

5.  Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.

Authors:  Adrian M Di Bisceglie; Andre C Lyra; Myron Schwartz; Rajender K Reddy; Paul Martin; Gregory Gores; Anna S F Lok; Khozema B Hussain; Robert Gish; David H Van Thiel; Zobair Younossi; Myron Tong; Tarek Hassanein; Luis Balart; Jacquelyn Fleckenstein; Stephen Flamm; Andres Blei; Alex S Befeler
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

Review 6.  Hepatocellular carcinoma: overcoming challenges in disease management.

Authors:  Robert G Gish
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.